- Article
- Source: Campus Sanofi
- 16 Jul 2025
Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity
MAT-BH-2500365-V1-June 2025
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
MAT-BH-2500365-V1-June 2025